Clinical Trials Browser

Advanced Solid Tumor × Nivolumab × 30 days × Clear all

NCT04735978 2026-02-27

Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours

Phase 1 Active not recruiting

Other solid neoplasm

Advanced Solid Tumor